Aberrant expression of CCNB2 has been observed in various cancer types, including lung, bladder, and breast cancers 15, and elevated CCNB2 expression is associated with unfavorable prognosis in hepatocellular carcinoma (HCC) patients 16. This evidence concerns the gene CCNB2 and breast cancer.